Clinical Trial Details
| Trial ID: | L3929 |
| Source ID: | NCT01196546 |
| Associated Drug: | Vildagliptin/Metformin |
| Title: | Efficacy and Safety of Combination Therapy of Vildagliptin/Metformin in Patients in Type 2 Diabetes Mellitus (T2DM) |
| Acronym: | |
| Status: | COMPLETED |
| Study Results: | NO |
| Results: | |
| Conditions: | Type 2 Diabetes Mellitus |
| Interventions: | DRUG: vildagliptin/metformin |
| Outcome Measures: | Primary: HbA1c reduction, 24 weeks after treatment | Secondary: Proportion of patients who achieve target of HbA1c<6.5% at the end of study, 24 weeks after treatment|To evaluate the effect of combination therapy of vildagliptin (50 mg) plus metformin (500 or 1000 mg) twice daily on FPG and BMI, safety and tolerability profiles, 24 weeks after treatment |
| Sponsor/Collaborators: | Sponsor: Novartis |
| Gender: | ALL |
| Age: | ADULT, OLDER_ADULT |
| Phases: | PHASE4 |
| Enrollment: | 161 |
| Study Type: | INTERVENTIONAL |
| Study Designs: | Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT |
| Start Date: | 2010-03 |
| Completion Date: | 2011-10 |
| Results First Posted: | |
| Last Update Posted: | 2017-08-01 |
| Locations: | BMA Medical College and Vajira Hospital, Bangkok, Thailand|King Chulalongkorn Memorial Hospital, Bangkok, Thailand|Phamongkutklao Hospital, Bangkok, Thailand|Police General Hospital, Bangkok, Thailand|Siriraj Hospital, Bangkok, Thailand|Khon Kaen Hospital, Khon Kaen, Thailand|Fort Suranaree Hospital, Nakhon Ratchasima, Thailand|Maharat Nakhon Ratchasima Hospital, Nakhon Ratchasima, Thailand |
| URL: | https://clinicaltrials.gov/show/NCT01196546 |
